Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Hearing Loss 2Deafness 2

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Has results × Ankle Brachial Index × Clear all
NCT01864291 2020-06-02

ABI

Massachusetts Eye and Ear Infirmary

Phase NA Terminated
9 enrolled 10 charts

Deafness, Hearing Loss

NCT01736267 2020-05-06

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

Massachusetts Eye and Ear Infirmary

Phase NA Terminated
3 enrolled 8 charts

Deafness, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡